awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34805650-2582AA3F-DB7E-41BB-B4DF-AA8FB465906F
Q34805650-2582AA3F-DB7E-41BB-B4DF-AA8FB465906F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34805650-2582AA3F-DB7E-41BB-B4DF-AA8FB465906F
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS S
P2860
Q34805650-2582AA3F-DB7E-41BB-B4DF-AA8FB465906F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34805650-2582AA3F-DB7E-41BB-B4DF-AA8FB465906F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61ef56f09d480e8068464c2ed41ee37a9eb0cde7
P2860
Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.